Non-commercial trials  
  Trial Study description Status  
  SENTIX
documents available here
Sentinel node in cervix cancer
A prospective observational trial on sentinel lymph node biopsy in patients with early stage cervical cancer
The target size of the group: 300 patients
Estimated enrollment period: 2016 – 2018
Collaborative opportunities: other centers may join the study if they fulfill the trial criteria ( more information can be sent by the CEEGOG office on request)
Ongoing  
  HE4-FU-OVCA
documents available here
The Role of HE4 in the Follow-up of Advanced Ovarian, Fallopian Tube and Primary Peritoneal Cancer
A prospective multicentre observational study
The target size of the group: 150 patients
Collaborative opportunities: the opportunity to join the study is still available (for more information, you are welcome to contact the CEEGOG office)
Ongoing  
  DGCG-ENGOT/EORTC 55102 A phase III Trial of postoperative chemotherapy or no further treatment for patients with node-negative stage I-II intermediate or high risk endometrial cancer
The target size of the group: 478
Ongoing  
  SALVAGE study A retrospective trial on patients who have undergone salvage surgery for a recurrent uterine or cervical cancer
Salvage database – data from 620 patients collected, currently results analysed
Closed  
         
         
         
  Commercial trials  
  Trial Study description Status  
  Javelin Ovarian 200 A phase 3, multicenter, randomized, open-label study of Avelumab (MSB0010718C) alone or in combination with Pegylated liposomal Doxorubicin versus Pegylated Liposomal Doxorubicin alone in patients with platinum-resistant/refractory ovarian cancer
Approximately 550 patients will be randomized
Ongoing  
  SOTIO clinical trials SOV01 A randomized, open-label, three-arm, multi-center Phase II clinical trial evaluating effect of addition of DCVAC/ OvCa to first line standard chemotherapy (carboplatin and paclitaxel) in women with newly diagnosed epithelial ovarian carcinoma

SOV02 A randomized, open-label, parallel group, multi-center Phase II clinical trial evaluating effect of addition of DCVAC/ OvCa to standard chemotherapy (carboplatin and gemcitabine) in women with relapsed platinum sensitive epithelial ovarian carcinoma

SOV03 A randomized, open-label, parallel group, multi-center Phase II clinical trial evaluating effect of addition of DCVAC/ OvCa to standard chemotherapy in women with relapsed platinum resistant epithelial ovarian carcinoma
Closed  
  MILO study MEK Inhibitor in Low-grade Serous Ovarian Cancer
A Multinational, Randomized, Open-label Phase 3 Study of MEK162 vs. Physician’s Choice Chemotherapy in Patients with Recurrent or Persistent Low-grade Serous Carcinomas of the Ovary, Fallopian Tube or Primary Peritoneum
Closed  
  ENGOT-OV16 / NOVA Niraparib in OVArian cancer
A randomized, double-blind phase 3 trial of maintenance with niraparib vs placebo in patients with platinum-sensitive recurrent ovarian cancer
Closed